Contact
Please use this form to send email to PR contact of this press release:
FDA approves mitomycin intravesical solution for recurrent low-grade intermediate-risk non-muscle invasive bladder cancer
TO:
Please use this form to send email to PR contact of this press release:
FDA approves mitomycin intravesical solution for recurrent low-grade intermediate-risk non-muscle invasive bladder cancer
TO: